Matches in DBpedia 2016-04 for { ?s ?p "Cellectis a biopharmaceutical company focused on developing immunotherapies based on genome-edited CAR T-cells (UCARTs). Cellectis has been working in the gene editing field for 16 years to design novel products, particularly immune therapies for cancer."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Cellectis abstract "Cellectis a biopharmaceutical company focused on developing immunotherapies based on genome-edited CAR T-cells (UCARTs). Cellectis has been working in the gene editing field for 16 years to design novel products, particularly immune therapies for cancer.".
- Q2943995 abstract "Cellectis a biopharmaceutical company focused on developing immunotherapies based on genome-edited CAR T-cells (UCARTs). Cellectis has been working in the gene editing field for 16 years to design novel products, particularly immune therapies for cancer.".
- Cellectis comment "Cellectis a biopharmaceutical company focused on developing immunotherapies based on genome-edited CAR T-cells (UCARTs). Cellectis has been working in the gene editing field for 16 years to design novel products, particularly immune therapies for cancer.".
- Q2943995 comment "Cellectis a biopharmaceutical company focused on developing immunotherapies based on genome-edited CAR T-cells (UCARTs). Cellectis has been working in the gene editing field for 16 years to design novel products, particularly immune therapies for cancer.".